Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

US precision medicine push gathers momentum

Hopes to ‘revolutionise’ medicines through creation of shared healthcare databases

- PMLiVE

New UK Cancer Drugs Fund takes shape

NICE to manage access to cancer treatments from 1 July

- PMLiVE

Lime Advertising promotes Rachel Lamb

She becomes the agency’s art director

- PMLiVE

Richard Douglas joins Incisive Health

He takes up a role at the healthcare comms consultancy as senior counsel

Bayer symbol

Bayer picks strategy head for top post

Werner Baumann will take over from Dr Marijn Dekkers

- PMLiVE

FDA rejects PTC’s application for muscular dystrophy drug

Says Translarna filing not “sufficiently complete” to permit full review

- PMLiVE

ViiV and Janssen take long-acting HIV regimen into phase III

Cabotegravir and rilpivirine injectable-therapy tipped as future blockbuster

- PMLiVE

Dr Robert Califf confirmed as new head of the FDA

US Senate votes in favour of his appointment to lead the regulator

Novartis building

Novartis claims FDA breakthrough status for leukaemia treatment

Designation could speed up development and access for Novartis’ PKC412

- PMLiVE

Damian Eade rejoins Cello Health Insight

Takes up newly-created role as global head of digital

- PMLiVE

Ashfield Healthcare expands its board of directors

Seven new members join the board

Eli Lilly HQ

Lilly wins European approval for lung cancer drug Portrazza

First biologic licenced in EU as a first-line treatment for adults with NSCLC

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links